期刊
ACS BIOMATERIALS SCIENCE & ENGINEERING
卷 8, 期 4, 页码 1544-1553出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsbiomaterials.1c01305
关键词
controlled release; transdural drug delivery; microneedles; polypyrrole; conductive polymer; spinal cord injury
资金
- University of Washington Neurological Surgery Department
- UW Mary Gates Endowment
- UW Institute of Neuroengineering
- Washington Research Foundation
- National Science Foundation [NNCI-1542101]
After spinal cord injury, inflammation and cytotoxicity cause further damage to neural cells. Research has found that the progression of this secondary injury can be reduced by administering anti-inflammatory drugs through a microneedle array for local delivery.
After the spinal cord injury, inflammation and cytotoxicity cause further damage to neural cells. The progression of this secondary injury might be reduced by the administration of anti-inflammatory drugs. To allow the local delivery of such drugswhile minimizing dural opening, we have created a polypyrrole(PPy)-coated microneedle array using a microscale three-dimen-sional (3D) printing technology that facilitates electronicallycontrolled encapsulation and the transdural release of drugs. PPymicroneedles demonstrated an electronically controlled release ofsteroid dexamethasone (Dexa) in a novel in vitro transdural modeland in vivo. The biological activity of the device was then tested by the electronic release of Dexa into an in vitro model ofneuroinflammation, using activated microglia. Following electrically activated Dexa release, inflammation was reduced, asdemonstrated by a decrease in nitric oxide and proinflammatory cytokines Il-6 and MCP-1. These results demonstrate the feasibilityof PPy-coated microneedles for the transdural delivery of anti-inflammatory drugs to the central nervous system
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据